Emerging research presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting is reinforcing a critical shift ...

The FDA has approved Johnson & Johnson’s Icotyde (icotrokinra), the first oral IL‑23 receptor‑targeted peptide for moderate‑to‑severe plaque psoriasis in adults and adolescents. Data from Phase 3 ...

Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases, today ...

Psoriasis isn’t just a skin condition — it’s an autoimmune disease that can affect your whole body and wellbeing. From medical treatments to lifestyle changes, there are more ways than ever to manage ...

Having been targeted by online trolls during last year’s Women’s Rugby World Cup for wearing pink bows in her hair, Wales’ ...

Immunotherapy has transformed cancer treatment by helping the body’s immune system recognize and attack cancer cells more ...

Mindera Health, a leader in precision medicine for dermatological conditions, today announced it has received approval from the New York State Department of Health for its Mind.Px test. Mind.Px is a ...

Strong recommendation with high certainty of clinical evidence underscores proven efficacy, safety, and tolerability of ZORYVE cream as a ...

At the recent American Academy of Dermatology (AAD) annual meeting, new phase III data from the LATITUDE-PsO-3001 and ...

Finding the right dermatologist often means juggling multiple appointments across different offices. One doctor examines a suspicious mole. Another performs the biopsy. A third handles treatment. The ...

Prefilled syringes (PFS) preferred on pharmacy benefit; vials preferred on medical benefit RALEIGH, N.C., April 20, 2026 /PRNewswire/ -- Accord BioPharma, the U.S. specialty division of Intas ...

Dealing with dry, reactive skin in perimenopause? Naomi Watts’ Stripes Beauty line is designed for midlife skin changes, ...